Skip to main content
. Author manuscript; available in PMC: 2013 Jan 1.
Published in final edited form as: J Neuropathol Exp Neurol. 2012 Jan;71(1):73–82. doi: 10.1097/NEN.0b013e318240fa65

Table 3.

Concordance Between 1p/19q Fluorescence In Situ Hybridization and PCR-Based Microsatellite Loss of Heterozygosity Data Is Further Refined by 10q Status

1p/19q FISH 10q status 1p/19q PCR microsatellite-based LOH % FISH-PCR concordance
codeleted Intact
original criteria codeleted 10q intact 52 7 88.1
10q LOH 4 13 23.5
intact 10q intact 0 13 100.0
10q LOH 1 8 88.9
modified criteria codeleted 10q intact 49 5 90.7
10q LOH 4 10 28.6
intact 10q intact 3 15 83.3
10q LOH 1 11 91.7

Ninety-eight World Health Organization grade II and III oligodendrogliomas were tested for 1p/19q codeletion by FISH and PCR-based LOH analysis and for 10q deletion. Both by original and more stringent modified criteria, if a case was 1p/19q-codeleted and intact for 10q, PCR analysis also called the case codeleted about 90% of the time. If a case was called 1p/19q-codeleted by FISH yet had 10q LOH, PCR analysis called the same tumor negative for codeletion over 70% of the time. If a tumor was 1p/19q intact by either original or modified FISH criteria and also 10q intact, PCR analysis also called it 1p/19q intact 80–100% of the time; the presence of 10q LOH did not appreciably change that proportion (about 90%). FISH = fluorescence in situ hybridization; LOH = loss of heterozygosity; PCR = polymerase chain reaction.